Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Analyzing the Future of Series Shares

Shares of Series rose to $174.96 during today's afternoon trading session. Despite the 29.1% change, the Large-Cap Semiconductors company still trades 13.89% above its average analyst target price of $153.62. So there may be further downside for the Semiconductors stock. Series has target prices ranging from $80.0 to $200.0 per share, and its average rating is buy.

Series has an average level of shares sold short, at 9.2% of its total share float. The stock's short ratio (also called days to cover) is 2.21. The company's insiders own 13.54% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 74.0% of Series's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Series

Date Reported Holder Percentage Shares Value
2025-03-31 FMR, LLC 15% 24,122,742 $4,220,515,102
2025-03-31 Vanguard Group Inc 6% 9,297,476 $1,626,686,463
2025-03-31 Alliancebernstein L.P. 5% 8,401,019 $1,469,842,340
2025-03-31 Blackrock Inc. 3% 4,652,820 $814,057,418
2025-03-31 Atreides Management, LP 3% 4,652,264 $813,960,140
2025-03-31 Shaw D.E. & Co., Inc. 2% 3,376,245 $590,707,847
2025-03-31 Invesco Ltd. 1% 1,881,519 $329,190,576
2025-03-31 Fred Alger Management, LLC 1% 1,560,033 $272,943,384
2025-03-31 State Street Corporation 1% 1,539,096 $269,280,246
2025-03-31 Renaissance Technologies, LLC 1% 1,426,700 $249,615,441
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS